Search by Drug Name or NDC
NDC 00023-9637-04 Oxytrol for Women 3.9 mg/d Details
Oxytrol for Women 3.9 mg/d
Oxytrol for Women is a TRANSDERMAL PATCH in the HUMAN OTC DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is OXYBUTYNIN.
MedlinePlus Drug Summary
Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
Related Packages: 00023-9637-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Oxybutynin Transdermal Patch
Product Information
| NDC | 00023-9637 |
|---|---|
| Product ID | 0023-9637_bfd95021-d60e-4842-be48-20cfab631ccd |
| Associated GPIs | 54100045008720 |
| GCN Sequence Number | 071392 |
| GCN Sequence Number Description | oxybutynin PATCH TD 4 3.9MG/24HR TRANSDERM |
| HIC3 | R1A |
| HIC3 Description | URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT |
| GCN | 35162 |
| HICL Sequence Number | 025056 |
| HICL Sequence Number Description | OXYBUTYNIN |
| Brand/Generic | Brand |
| Proprietary Name | Oxytrol for Women |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Oxybutynin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | PATCH |
| Route | TRANSDERMAL |
| Active Ingredient Strength | 3.9 |
| Active Ingredient Units | mg/d |
| Substance Name | OXYBUTYNIN |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA202211 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00023-9637-04 (00023963704)
| NDC Package Code | 0023-9637-04 |
|---|---|
| Billing NDC | 00023963704 |
| Package | 16 PATCH in 1 CARTON (0023-9637-04) / 4 d in 1 PATCH |
| Marketing Start Date | 2016-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.61525 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | OXYTROL FOR WOMEN 3.9 MG/24HR |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis